Submit Your Feeds

Business News • PR NewsWire • Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress

Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress
Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress

UPPSALA, Sweden, April 17, 2018 /PRNewswire/ -- New results from a Pfizer study on Ibrance® (palbociclib, Pfizer) of women with metastatic breast cancer demonstrate that DiviTum can provide fast evaluation of biologic effect demonstrating CDK 4/6 inhibition. The study, presented...

View More : https://www.prnewswire.com/news-releases/biovica-international---positive-results-with-divitum-from-new-pfizer-study-pre...
Releted News by prnewswire
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress
Wirecard's boon Mobile Payment Solution Now Available on Fitbit Pay
Noo Nectar liquid nootropic stack with more than 20 nutrient-rich ingredients expanding distribution in U.S.
Home Sitemap Contact Us
© businessNewsNewsNews.com